Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Vaccinated groups at highest risk of Covid-19 hospitalisation and death identified using new QCovid tool

Big data COVID-19 QResearch

New algorithm predicts those most at risk of serious Covid-19 outcomes from 14 or more days after second vaccination dose, when substantial immunity is expected to have developed Authors hope this new risk tool will allow those who perceive risk to be high to make more informed decisions regarding shielding and potentially inform policy and clinical decisions on booster vaccine doses and monoclonal antibodies

Can electronic cigarettes help people quit smoking? (Updated)

Research methods & EBM

Published this week is the fourth update of the Cochrane review of ‘Electronic cigarettes for smoking cessation’, and the second since it switched to a living review format in October 2020. This review brings together the most up to date research findings on the effect and safety of using electronic cigarettes to help people to stop smoking.

MSc EBHC students awarded EBHC Dissertation Prize for outstanding Dissertation

Awards & appointments Research methods & EBM Students

Congratulations to Michael Tringale, who recently completed the MSc in Evidence-Based Health Care, and Claire Duddy, who recently completed the MSc in EBHC Systematic Reviews, as they are both awarded this year's EBHC Dissertation Prize for outstanding dissertation.

Oxford announces the founding of the new Bennett Institute for Applied Data Science

Awards & appointments Bennett Institute Big data

The Bennett Institute for Applied Data Science at the University of Oxford has been established to pioneer the better use of data, evidence and digital tools in healthcare and policy, optimizing the impact of interventions to achieve improved outcomes. The Institute has been made possible due to a generous donation from The Peter Bennett Foundation

New collaboration to assess revolutionary multi-cancer blood test in trial, for future use in the NHS

The Nuffield Department of Primary Care Health Sciences is co-leading on a recently announced nation-wide collaborative project to evaluate a new technology which aims to detect early signs of multiple types of cancer.

Department cancer-risk research featured in special edition of PLOS Medicine focussed on advances in early cancer detection

Big data Cancer Digital health & innovation

The research, led by researchers at the Nuffield Department of Primary Care Health Sciences, is highlighted in a special collection of studies that focus on early cancer detection, hailed by the Editors as “cutting edge, and potentially scalable, innovations that have the potential to inform research, policy, and clinical cancer management.”

Covid-19, not vaccination, presents biggest blood clot risks

Big data COVID-19 Infection & acute care

Oxford researchers have today announced the results of a blood clot study, suggesting lower risk with vaccine than infection.

COVID-19 population-based study wins journal award

Big data COVID-19 Infection & acute care QResearch

Research into the risk of hospital admission from COVID-19 is recognised with a "Best Research Paper Award" from the journal Heart.

New research to explore family experiences of long COVID

Awards & appointments COVID-19

The Nuffield Department of Primary Care Health Sciences is delighted to announce that it has been awarded £557,674 to investigate how families are managing to cope with ‘long covid’ and to understand how best they can be supported.

People with learning disabilities “extremely vulnerable” to the effects of COVID-19, finds study

Big data COVID-19

The results, from within the OpenSAFELY platform, are based on electronic health records for more than 17 million people registered with a general practice in England linked to hospital admission and mortality data.

COVID-19 risk prediction tool wins national award

Big data COVID-19

The QCovid®-powered COVID-19 Population Risk Assessment, developed by a cross-organisational team and rolled across NHS England, has won the Florence Nightingale Award for Excellence in Healthcare Data Analytics.

Benefit-to-harm balance of statins for healthy adults "generally favourable", suggests Oxford-led research

Cardiovascular & metabolic DPhil

Statins are associated with a small increased risk of side effects in patients without a history of heart disease, but these effects are mild compared with the potential benefits of treatment in preventing major cardiovascular events, finds a study led by Oxford University researchers.

PRINCIPLE trial 'highly commended' for innovative use of health data

Big data COVID-19 Clinical trials

The PRINCIPLE trial has been highly commended at the Health Data Research UK Awards for the way in which patient data is utilised so participants are contacted about the trial soon after receiving a positive test result.

Ethnic minority children may be disproportionately impacted by COVID-19, suggests analysis

Big data COVID-19 DPhil

There are higher proportions of ethnic minority children in England testing positive for COVID-19 than white children, with Asian children more likely to be admitted to hospital with the illness, finds an observational analysis of 2.6 million healthcare records led by Oxford University researchers.

Celebrating International Clinical Trials Day 2021

COVID-19 Clinical trials

Each year, International Clinical Trials Day recognises the people who conduct clinical trials, giving our community a chance to say thank you for everything they do to improve public health. This year our trials unit staff are sharing what makes them proud to be part of Oxford’s Primary Care Clinical Trials Unit.

New study shows potential link between bodyweight and risk of severe COVID-19, especially for younger adults

Big data COVID-19 QResearch

The first large study to report the effect of bodyweight on risk of worse outcomes from COVID-19 across the full range of body mass index (BMI) is published today in The Lancet Diabetes and Endocrinology journal.

Foods associated with an increased risk of cardiovascular disease and death in middle-age identified

Cardiovascular & metabolic Health behaviours

Two common dietary patterns identified in British adults, which include high intakes of chocolate and confectionary, may be associated with an increased risk of cardiovascular disease and death in middle-age, according to a study published in the open access journal BMC Medicine by Oxford University researchers.

Load More

Sign-up for our newsletters

Contact our communications team

Our research media coverage

Our COVID-19 media coverage


Opinions expressed are those of the authors and not of Oxford University. Readers' comments will be moderated - see our guidelines for further information.